Target intelligence / Profile preview

Membrane attack complex (C5b-9) (MAC)

Target
MAC
Molecular classification
Protein complex, Immune effector complex, Pore-forming complex, Member of the MACPF/cholesterol-dependent cytolysin superfamily, Other (does not fit standard receptor/enzyme/channel/etc.)
01

Overview

The membrane attack complex (MAC, C5b-9) is a pore-forming protein complex assembled on cell membranes during terminal complement activation. It consists of complement components C5b, C6, C7, C8, and multiple copies of C9, forming a transmembrane ring. MAC assembly starts with C5 cleavage, yielding C5b, which binds sequentially to C6, C7, C8, and then polymerizing C9 molecules. This process results in a large β-barrel channel that disrupts membrane integrity and causes cell lysis––critical for innate host defense against microbes. Sublytic MAC quantities can induce cell proliferation, survival signaling, and immune modulation, contributing to both normal physiology and disease. Excess or misdirected MAC formation is implicated in autoimmune, inflammatory, and tissue-destructive diseases; thus, MAC and its formation are therapeutic targets in these contexts. The soluble form of MAC (sC5b-9) is clinically used as a biomarker for complement activation.

Other names
Membrane attack complexMACTerminal complement complex (TCC)C5b-9 complexSoluble C5b-9 (sC5b-9; refers to the fluid-phase form)
02

Mechanism of action

Blockade of C5 cleavage (preventing formation of C5b, and thus MAC) Inhibition or neutralization of MAC or its assembly proteins (prevention of pore formation and cell lysis) Enhancement of MAC clearance (soluble MAC complexes prevented from inserting into host tissues)

03

Biological functions

Innate immune defenseCell death (cytolysis via membrane pore formation)Cell signaling, proliferation, and differentiation (sublytic MAC)Apoptosis inhibition (sublytic MAC)Immune response mediation
04

Disease associations

InflammationAutoimmune diseaseInfection (host defense against microbes)Cardiovascular disease (e.g., atherosclerosis, tissue injury)Other (complement-mediated tissue injury, transplant rejection)
05

Safety considerations

Increased infection risk (especially meningococcal and other encapsulated bacteria) due to complement inhibitionRisk of excessive immune suppressionPotential off-target tissue injury from unregulated complement activationAutoimmune reactions if host cell protection fails
06

Interacting drugs

Eculizumab (C5 inhibitor, blocks MAC formation)

4 more in the full profile.

07

Biomarkers

Plasma/serum sC5b-9 levels (soluble MAC or TCC; used for monitoring complement activation in disease and treatment efficacy)

Beyond the preview

Go deeper on Membrane attack complex (C5b-9) (MAC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Membrane attack complex (C5b-9) (MAC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call